UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis

Respiratory medicine, 2013-07, Vol.107 (7), p.1008-1013

2013

Volltextzugriff (PDF)

The diagnosis and management of chronic cough

The European respiratory journal, 2004-09, Vol.24 (3), p.481-492

2004

Volltextzugriff (PDF)

Patient characteristics and triggers eliciting refractory chronic cough

The World Allergy Organization journal, 2020-08, Vol.13 (8), p.100209, Article 100209

2020

Volltextzugriff (PDF)

Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan

International journal of cardiology, 2010-10, Vol.144 (3), p.e43-e45

2010

Volltextzugriff (PDF)

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

The World Allergy Organization journal, 2020-08, Vol.13 (8), p.100203, Article 100203

2020

Volltextzugriff (PDF)

29 Ivacaftor treatment is associated with a decline in symptoms of extra-oesophageal reflux in patients with cystic fibrosis and the G551D mutation

Journal of cystic fibrosis, 2016-06, Vol.15, p.S58-S59

2016

Volltextzugriff (PDF)

Fosfomycin for Pseudomonas -related exacerbations of cystic fibrosis

International journal of antimicrobial agents, 2008-11, Vol.32 (5), p.461-463

2008

Volltextzugriff (PDF)

Characterization of a Hek293 Cell Line Permanently Co-Expressing the Cough Receptors Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (Trpa1 and Trpv1)

Pulmonary pharmacology & therapeutics, 2011, Vol.24 (3), p.e8-e8

2011

Volltextzugriff (PDF)

Antitussive drugs--past, present, and future

Pharmacological reviews, 2014-04, Vol.66 (2), p.468-512

2014

Volltextzugriff (PDF)

Drug-Induced Cough

Physiological research, 2020-03, Vol.69 (Suppl 1), p.S81-S92

2020

Volltextzugriff (PDF)

Cough Hypersensitivity Syndrome: A Distinct Clinical Entity

Lung, 2011-02, Vol.189 (1), p.73-79

2011

Volltextzugriff (PDF)

The effect of pH on citric acid cough challenge: A randomised control trial in chronic cough and healthy volunteers

Respiratory physiology & neurobiology, 2018-11, Vol.257, p.51-54

2018

Volltextzugriff (PDF)

Alert system design based on experimental findings from long-term unobtrusive monitoring in COPD

Biomedical signal processing and control, 2021-01, Vol.63, p.102205, Article 102205

2021

Volltextzugriff (PDF)

159 Fundoplication for reflux induced cough in cystic fibrosis

Journal of cystic fibrosis, 2007, Vol.6, p.S39-S39

2007

Volltextzugriff (PDF)

Performance Requirements for Cough Classifiers in Real-World Applications

2020 28th European Signal Processing Conference (EUSIPCO), 2021, p.96-100

2021

Volltextzugriff (PDF)

Tackling the heart sink symptom: ERS guidelines on chronic cough

Breathe (Lausanne, Switzerland), 2004-12, Vol.1 (2), p.89-90

Morice, A.H.

2004

Volltextzugriff (PDF)

Chronic cough: diagnosis, treatment and psychological consequences

Breathe (Lausanne, Switzerland), 2006-12, Vol.3 (2), p.164-174

Morice, A.H.

2006

Volltextzugriff (PDF)

Clinical cough and its mechanisms

Respiratory physiology & neurobiology, 2006-07, Vol.152 (3), p.363-371

2006

Volltextzugriff (PDF)

Hydrogen peroxide — an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction

Pharmacology & therapeutics (Oxford), 2000-11, Vol.88 (2), p.153-161

2000

Volltextzugriff (PDF)

A28 Lung ventilation scintigraphy used to assess aerosol nebulizer deposition and repeatability in CF

Nuclear medicine communications, 2006-07, Vol.27 (7), p.A6-A7

2006

Volltextzugriff (PDF)

Understanding cough

The European respiratory journal, 2002-01, Vol.19 (1), p.6-7

2002

Volltextzugriff (PDF)

The novel budesonide/formoterol pMDI is therapeutically equivalent to budesonide/formoterol Turbuhaler® in children with asthma

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S209-S209

2005

Volltextzugriff (PDF)

Therapeutic equivalence of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S2-S2

2005

Volltextzugriff (PDF)

Comparable safety of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S3-S3

2005

Volltextzugriff (PDF)

Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography

The European respiratory journal, 2002-06, Vol.19 (6), p.1214; author reply 1214-1220

2002

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(54)
Tagungsberichte
(2)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis

The diagnosis and management of chronic cough

Patient characteristics and triggers eliciting refractory chronic cough

Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

29 Ivacaftor treatment is associated with a decline in symptoms of extra-oesophageal reflux in patients with cystic fibrosis and the G551D mutation

Fosfomycin for Pseudomonas -related exacerbations of cystic fibrosis

Characterization of a Hek293 Cell Line Permanently Co-Expressing the Cough Receptors Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (Trpa1 and Trpv1)

Antitussive drugs--past, present, and future

Drug-Induced Cough

Cough Hypersensitivity Syndrome: A Distinct Clinical Entity

The effect of pH on citric acid cough challenge: A randomised control trial in chronic cough and healthy volunteers

Alert system design based on experimental findings from long-term unobtrusive monitoring in COPD

159 Fundoplication for reflux induced cough in cystic fibrosis

Performance Requirements for Cough Classifiers in Real-World Applications

Tackling the heart sink symptom: ERS guidelines on chronic cough

Chronic cough: diagnosis, treatment and psychological consequences

Clinical cough and its mechanisms

Hydrogen peroxide — an intracellular signal in the pulmonary circulation: involvement in hypoxic pulmonary vasoconstriction

A28 Lung ventilation scintigraphy used to assess aerosol nebulizer deposition and repeatability in CF

Understanding cough

The novel budesonide/formoterol pMDI is therapeutically equivalent to budesonide/formoterol Turbuhaler® in children with asthma

Therapeutic equivalence of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

Comparable safety of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography

Aktive Filter

Suchergebnisse filtern